Bisoprolol Transdermal Patch for Perioperative Care of Non-cardiac Surgery in Patients with Hypertrophic Obstructive Cardiomyopathy

Bisoprolol Transdermal Patch for Perioperative Care of Non-cardiac Surgery in Patients with Hypertrophic Obstructive Cardiomyopathy - Bisoprolol Transdermal Patch for HOCM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036703

Enrollment

Registered

2019-05-10

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic obstructive cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: consecutive cases of HOCM with the patients using the bisoprolol transdermal patch during perioperative care

Exclusion criteria

Exclusion criteria: We excluded patients who exhibited only sigmoid septum but without significant hypertrophy.

Design outcomes

Primary

Measure	Time frame
Hemodynamic and echocardiographic features before and after patients switched from oral bisoprolol to transdermal patch therapy or started transdermal patch therapy as a new beta blocker medication	—

Secondary

Measure	Time frame
cardiovascular complications (all cause death, cardiac death, heart failure, ventricular tachycardia, and ventricular fibrillation) in the perioperative period	—

Countries

Japan

Contacts

Public ContactYoichi Imori

Nippon Medial School Hospital Department of Cardiovascular Medicine

s9012@nms.ac.jp03-3822-2131

Outcome results